⚠️ You're offline
🏠 Home 🏆 WC 2026 Schedule local International Middle East Economy Technology Sports World Cup News Health Environment Culture Society

Emirates Pharmaceutical Company approves the innovative “Etkamah” to treat breast cancer associated with ESR1 mutation

Health 11/06/2026 البيان 👁 23
⚡ Quick Summary

Emirates Pharmaceutical Company approves the innovative “Etkamah” to treat breast cancer associated with ESR1 mutation

📖 Article source — 🌐 Arabic ← Back

🔖 Saved